Candidate vaccine by SII, Oxford varsity to join Ebola trial: WHO

The candidate vaccine developed by the Oxford University and the Serum Institute of India is among the two such vaccines added to the ongoing Ebola clinical trials, according to a World Health Organisation (WHO) statement, making it the first addition of candidate vaccines to the trials specifically targeting the Bundibugyo virus that has caused the current Ebola outbreak in the Democratic Republic of the Congo (DRC).
- EgyptAAIB partners with GB Auto to offer Genesis EV buyers 65% buyback guarantee
- SudanDrone attacks kill five children, injures 10 in Khartoum and Omdurman
- Saudi ArabiaBuilding an Arab American community
- OmanOman marks National Day with a new phase of developments
- UAEBrazil ex-leader Bolsonaro 'stable' in intensive care
- QatarQatar Charity provides food baskets to thousands of refugees in Djibouti
- BahrainBCFC Launches Ijarah Muntahia Bittamleek Financing
- IndiaUP: 13 children among 23 injured as cylinder explodes in councillor's home


